Literature DB >> 17127188

Gallstone disease: Primary and secondary prevention.

Niels G Venneman1, Karel J van Erpecum.   

Abstract

Several risk factors for cholesterol gallstone formation in the general population have been identified. There is a strongly increased risk of gallstone disease during prolonged fasting, rapid weight loss, total parenteral nutrition, and somatostatin(-analogue) treatment. The annual risk of biliary colic and gallstone complications in asymptomatic gallstone carriers has been investigated sparsely. In asymptomatic and symptomatic gallstone carriers, treatment with the hydrophilic bile salt ursodeoxycholic acid (UDCA) has been claimed to reduce the risk of biliary colic and gallstone complications such as acute cholecystitis and acute pancreatitis. Also, prophylactic cholecystectomy could be beneficial in certain subgroups of asymptomatic gallstone carriers. However, randomized, double-blind, placebo-controlled trials are lacking. In this review, strategies for the prevention of gallstone formation in the general population and in high-risk conditions are dealt with. Also, strategies for the prevention of biliary colic and gallstone complications in asymptomatic and symptomatic gallstone carriers are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127188     DOI: 10.1016/j.bpg.2006.03.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

Review 1.  Laparoscopic cholecystectomy: consensus conference-based guidelines.

Authors:  Ferdinando Agresta; Fabio Cesare Campanile; Nereo Vettoretto; Gianfranco Silecchia; Carlo Bergamini; Pietro Maida; Pietro Lombari; Piero Narilli; Domenico Marchi; Alessandro Carrara; Maria Grazia Esposito; Stefania Fiume; Giuseppe Miranda; Simona Barlera; Marina Davoli
Journal:  Langenbecks Arch Surg       Date:  2015-04-08       Impact factor: 3.445

2.  A population-based cohort study of symptomatic gallstone disease in diabetic patients.

Authors:  Chi-Ming Liu; Chung-Te Hsu; Chung-Yi Li; Chu-Chieh Chen; Meng-Lun Liu; Jorn-Hon Liu
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

3.  Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.

Authors:  Patricia A Thompson; Betsy C Wertheim; Denise J Roe; Erin L Ashbeck; Elizabeth T Jacobs; Peter Lance; María Elena Martínez; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

4.  Cholelithiasis in patients on the kidney transplant waiting list.

Authors:  André Thiago Scandiuzzi Brito; Luiz Sergio Azevedo; Willian Carlos Nahas; André Siqueira Matheus; José Jukemura
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

5.  Routine preoperative ultrasonography and selective cholecystectomy in laparoscopic Roux-en-Y gastric bypass. Why not?

Authors:  Alex Escalona; Camilo Boza; Rodrigo Muñoz; Gustavo Pérez; Sabina Rayo; Fernando Crovari; Luis Ibáñez; Sergio Guzmán
Journal:  Obes Surg       Date:  2007-12-15       Impact factor: 4.129

6.  Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.

Authors:  Sophie E Aapkes; Robbert J de Haas; Lucas H P Bernts; Charles J Blijdorp; Sosha E I Dekker; Maatje D A van Gastel; Esther Meijer; Abigail Veldman; Joost P H Drenth; Ron T Gansevoort
Journal:  Drugs R D       Date:  2021-03-29

7.  Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.

Authors:  Raphael B Stricker; Allison K Delong; Christine L Green; Virginia R Savely; Stanley N Chamallas; Lorraine Johnson
Journal:  Int J Gen Med       Date:  2011-09-06

8.  Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse.

Authors:  Matteo Micucci; Rita Aldini; Monica Cevenini; Carolina Colliva; Silvia Spinozzi; Giulia Roda; Marco Montagnani; Cecilia Camborata; Luca Camarda; Alberto Chiarini; Giuseppe Mazzella; Roberta Budriesi
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

9.  Regional variations in the treatment of gallstone disease may affect patient outcome: a large, population-based register study in sweden.

Authors:  Lisa Lindqvist; Gabriel Sandblom; Pär Nordin; Oskar Hemmingsson; Lars Enochsson
Journal:  Scand J Surg       Date:  2020-10-27       Impact factor: 2.360

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.